Literature DB >> 9860359

Overview of angiotensin II-receptor antagonists.

B Pitt1, M A Konstam.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9860359     DOI： 10.1016/s0002-9149(98)00807-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

Review 1.  The anti-ischemic potential of angiotensin-converting enzyme inhibition: insights from the heart outcomes prevention evaluation trial.

Authors:  B Pitt
Journal:  Clin Cardiol       Date:  2000-07       Impact factor: 2.882

2.  Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats.

Authors:  Mahmoud Teaima; Rehab Abdelmonem; Yomna A Adel; Mohamed A El-Nabarawi; Tayseer M El-Nawawy
Journal:  Drug Des Devel Ther       Date:  2021-11-10       Impact factor: 4.162

3.  Novel and validated titrimetric method for determination of selected angiotensin-II-receptor antagonists in pharmaceutical preparations and its comparison with UV spectrophotometric determination.

Authors:  Shrikant H Patil; Minakshi V Janjale
Journal:  J Pharm Anal       Date:  2012-04-09

4.  Simultaneous determination of telmisartan and amlodipine in human plasma by LC-MS/MS and its application in a human pharmacokinetic study.

Authors:  Vasu Babu Ravi; Jaswanth Kumar Inamadugu; Nageswara Rao Pilli; Vudagandla Sreenivasulu; Venkateswarlu Ponneri
Journal:  J Pharm Anal       Date:  2012-04-04

5.  QbD Consideration for Developing a Double-Layered Tablet into a Single-Layered Tablet with Telmisartan and Amlodipine.

Authors:  Joo-Eun Kim; Young-Joon Park
Journal:  Pharmaceutics       Date:  2022-02-08       Impact factor: 6.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.